Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,087 | 0,090 | 07:18 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
16.07. | SpineGuard Obtains US Patent on DSG-Enabled Active Safety Stop for Hand-Held Bone Drilling Power Tools in Free-Hand, Navigated or Robotically-Assisted Surgery | 344 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
09.07. | SpineGuard Announces Its H1 2025 Revenue | 281 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
29.04. | Presentation at CFA Congress of Positive Results Obtained for SpineGuard's New Ultrasound Technology | 395 | Business Wire | Feasibility of entry point and trajectory determination in vertebral drilling
Ideal complement of DSG real-time X Ray-free guidance technology
Collaboration with the LIB and ISIR... ► Artikel lesen | |
15.04. | SpineGuard Announces Full-Year 2024 Financial Results and First Quarter 2025 Sales | 383 | Business Wire | Significant reduction in losses of €1.1 million, with consolidated net income improving by 26% in 2024
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys... ► Artikel lesen | |
09.04. | SpineGuard and Omnia Medical Announce the Signature of a Binding Term Sheet for the Transfer of SpineGuard Inc. | 322 | Business Wire | Taking a new strategic step forward in the implementation of the common roadmap established by the two companies announced on January 6, 2025 Integration of PediGuard systems into Omnia... ► Artikel lesen | |
14.03. | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | 1.585 | Xetra Newsboard | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
10.02. | SpineGuard Announces the Commercial Launch of its "PsiFGuard" New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion | 422 | Business Wire | Innovation developed in partnership with the US company Omnia Medical Omnia launched PsiFGuard at the NANS convention in Orlando, from Jan. 30th to Feb. 1st, 2025
Regulatory News:
SpineGuard... ► Artikel lesen | |
10.01. | SpineGuard Reports Its Full-Year 2024 Revenue | 656 | Business Wire | +8% growth globally, +20% in the US
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology... ► Artikel lesen | |
SPINEGUARD Aktie jetzt für 0€ handeln | |||||
07.01. | SpineGuard Completes a Bond Financing to Support the Deployment of Its New Products | 1.007 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
06.01. | SpineGuard and Omnia Medical Announce the Extension of Their Strategic Partnership | 529 | Business Wire | Scope of initial agreement extended to other products and countries Reallocation of personnel and resources to bolster the launch of Omnia products in the United States including PsiFGuard
Regulatory... ► Artikel lesen | |
03.01. | SpineGuard announces its 2025 financial calendar | 522 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
09.10.24 | SpineGuard Announces Its Q3 2024 Revenue | 551 | Business Wire | Growth acceleration to continue in Q3 2024: +20% globally and +30% in the US Revenue up +13% over the first 9 months, to €3.6 million
Regulatory News:
SpineGuard (FR0011464452 ALSGD)... ► Artikel lesen | |
30.09.24 | SpineGuard Obtains FDA Clearance for Commercial Release of Its "PsiFGuard" New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion | 524 | Business Wire | Innovation developed in partnership with the US company Omnia Medical Key milestone for the deployment of the DSG technology in the United States
Regulatory News:
SpineGuard (FR0011464452... ► Artikel lesen | |
11.09.24 | SpineGuard Reports its H1 2024 Financial Results | 462 | Business Wire | Revenue growth by 10% at constant exchange rate Net loss reduced by 20% and EBITDA improved by 30%
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys... ► Artikel lesen | |
03.09.24 | SpineGuard obtains EC-MDR certification and launches its Threaded PediGuard for anterior spine surgery in Europe | 586 | Business Wire | Regulatory News:
SpineGuard (Paris:ALSGD)(FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 46,600 | -0,89 % | DAX kann Dow Jones nicht folgen - Commerzbank, Fresenius, Gerresheimer, Lufthansa, Nordex, ... | Mit leichten Verlusten startet der deutsche Aktienmarkt in die neue Börsenwoche. "Das Allzeithoch aus dem Juli bleibt zwar in Reichweite. Es gibt aber weiterhin zu wenig Käufer, die den DAX über die... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 47,190 | -0,11 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
TELADOC HEALTH | 6,677 | +0,42 % | Teladoc: A Telehealth Titan in Trouble? | ||
THERMO FISHER | 418,55 | -0,24 % | Thermo Fisher Scientific Opens Manufacturing Facility in Mebane, NC | ||
EUROFINS SCIENTIFIC | 65,30 | +0,18 % | Eurofins Scientific: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Studienergebnisse zeigen: Darmmikrobiom kann frühzeitig Aufschluss über das Risiko einer späteren Demenz-Erkrankung geben | EQS-News: SYNLAB AG
/ Schlagwort(e): Kooperation/Studienergebnisse
Studienergebnisse zeigen: Darmmikrobiom kann frühzeitig Aufschluss über das Risiko einer späteren Demenz-Erkrankung... ► Artikel lesen | |
DAVITA | 118,70 | +0,38 % | Ransomware-Angriff auf Gesundheitsriesen DaVita | ||
SPINEWAY | 0,120 | -1,32 % | Spineway: H1 2025 results - Continued improvement in results and financial position | Press release Ecully, July 30, 2025 - 7 p.m. SPINEWAY H1 2025 results Continued improvement in results and financial positionFull-year 2025 growth target confirmed In thousands of... ► Artikel lesen | |
DENTSPLY SIRONA | 12,360 | +0,24 % | Dentsply Sirona Posts Wider Loss In Q2 | WASHINGTON (dpa-AFX) - Dentsply Sirona posted a second quarter net loss of $45 million, or $0.22 per share, compared to a net loss of $4 million, or $0.02 per share, a year ago. Adjusted earnings... ► Artikel lesen | |
SMITH & NEPHEW | 16,005 | -1,11 % | Smith & Nephew Plc - Director/PDMR Shareholding | ||
SONIC HEALTHCARE | 13,432 | -1,15 % | SONIC HEALTHCARE LIMITED: Notification of cessation of securities - SHL | ||
EMPOWER CLINICS | - | - | Empower Clinics Inc. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
ONTRAK | 0,125 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 26.08.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 26.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 26.08.2025.ISIN NameAU0000006934 NEW... ► Artikel lesen | |
DIASORIN | 85,12 | -0,07 % | J.P. Morgan favors bioMérieux over Diasorin in new coverage call | ||
PATTERSON COMPANIES | 27,400 | 0,00 % | Patterson Companies Completes Acquisition by Patient Square Capital | Robert Rajalingam Appointed Chief Executive Officer and to Board of Directors
ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies ("Patterson" or the "Company"), a leading supplier of products... ► Artikel lesen |